eukaryotic translation initiation factor 2B subunit alpha
Dernière mise à jour 18 Aug 2020
Respecte les directives éditoriales
- TéléchargerTélécharger
- Partager
- Language
- Discussion
- Ask Patient
- Version audio
- Ajouter aux sources préférées sur Google
La EIF2B1 gene provides instructions for making one of five parts of a protein called eIF2B, specifically the alpha subunit of this protein. The eIF2B protein helps regulate overall protein production (synthesis) in the cell by interacting with another protein, eIF2. The eIF2 protein is called an initiation factor because it is involved in starting (initiating) protein synthesis.
Sélections vidéo pour GènesBibliothèque vidéo
Normal function
La EIF2B1 gene provides instructions for making one of five parts of a protein called eIF2B, specifically the alpha subunit of this protein. The eIF2B protein helps regulate overall protein production (synthesis) in the cell by interacting with another protein, eIF2. The eIF2 protein is called an initiation factor because it is involved in starting (initiating) protein synthesis.
Under some conditions, eIF2B increases protein synthesis by helping to recycle molecules called GTP, which carry energy to the initiation factor. Under other conditions, it slows protein synthesis by binding tightly to the initiation factor, which converts the eIF2B protein into an inactive form and prevents recycling of GTP.
Proper regulation of protein synthesis is vital for ensuring that the correct levels of protein are available for the cell to cope with changing conditions. For example, cells must synthesize protein much faster if they are multiplying than if they are in a resting state.
Conditions referring to this gene or chromosome
Other names
EI2BA_HUMAN
EIF-2B
EIF-2Balpha
EIF2B
EIF2BA
eukaryotic translation initiation factor 2B, subunit 1 (alpha, 26kD)
eukaryotic translation initiation factor 2B, subunit 1 alpha, 26kDa
MGC117409
MGC125868
MGC125869
Related patient information and medicines

Patient information leaflet
Faits et facteurs de risque du cancer du sein
What are the risk factors for breast cancer. Dr Sarah Jarvis MBE Although cancer du sein can develop for no apparent reason, there are certain facteurs de risque which increase the chance that breast cancer volonté develop. /health/breast-cancer-leaflet Most cases of breast cancer occur by chance. However, breast cancer does occur more.

Patient information leaflet
Causes du cancer
Certain facteurs de risque are known to increase the chance that one or more of votre cells will become abnormal and lead to cancer. How does cancer start. The body is made up from millions of tiny cells. Different parts of the body such as organs, bones, muscles, skin and blood are made up from different specialised cells. Most cells have a centre.

Patient information leaflet
Tests de coagulation sanguine
Tests de coagulation sanguine sont used à diagnose et assess bleeding problems and to monitor people who take warfarin or other anticoagulant medicines. You may be advised to have blood clotting tests: If you have a suspected bleeding disorder. For example, if you bleed a lot after cuts, or if you bruise easily. If you have certain liver diseases that can.

Patient information leaflet
Hémophilie
Hémophilie est a rare bleeding disorder that affects your ability to make a clot. The blood contains substances called clotting factors that work with platelets to form a clot. When you injure yourself the clot stops you bleeding. Haemophilia is a condition where there is a deficiency of clotting factors, so people with this condition usually have.

Patient information leaflet
Thalassémie
Qu'est-ce que thalassaemia. Thalassémie est un inherited (genetic) condition affecting the blood. There are different types of thalassaemia. What causes thalassaemia. The cause is an inherited (genetic) change, involving the genes which tell the body how to make an important chemical called haemoglobin. Haemoglobin is the chemical which carries oxygen.

Patient information leaflet
Tests de fonction hépatique
If the liver is swollen, through inflammation or disease, it can swell out from under the ribs and make your tummy swollen. Liver function Liver function The liver is a factory for the production and breakdown of carbohydrates, fats, proteins, hormones and other essential body chemicals, and helps dispose of waste products. This work is mainly.
Lectures complémentaires et références
- eukaryotic translation initiation factor 2B subunit alpha; MedlinePlus, National Library of Medicine.
- Dietrich J, Lacagnina M, Gass D, Richfield E, Mayer-Proschel M, Noble M, Torres C, Proschel C. EIF2B5 mutations compromise GFAP+ astrocyte generation in vanishing white matter leukodystrophy. Nat Med. 2005 Mar;11(3):277-83. doi: 10.1038/nm1195. Epub 2005 Feb 20.
- Eurekah Bioscience: Mechanism of Translation Initiation in Eukaryotes
- Fogli A, Boespflug-Tanguy O. The large spectrum of eIF2B-related diseases. Biochem Soc Trans. 2006 Feb;34(Pt 1):22-9. doi: 10.1042/BST20060022.
- Fogli A, Schiffmann R, Hugendubler L, Combes P, Bertini E, Rodriguez D, Kimball SR, Boespflug-Tanguy O. Decreased guanine nucleotide exchange factor activity in eIF2B-mutated patients. Eur J Hum Genet. 2004 Jul;12(7):561-6. doi: 10.1038/sj.ejhg.5201189.
- Li W, Wang X, Van Der Knaap MS, Proud CG. Mutations linked to leukoencephalopathy with vanishing white matter impair the function of the eukaryotic initiation factor 2B complex in diverse ways. Mol Cell Biol. 2004 Apr;24(8):3295-306. doi: 10.1128/MCB.24.8.3295-3306.2004.
- Molecular Biology of the Cell (fourth edition, 2002): The Phosphorylation of an Initiation Factor Globally Regulates Protein Synthesis
- Pavitt GD. eIF2B, a mediator of general and gene-specific translational control. Biochem Soc Trans. 2005 Dec;33(Pt 6):1487-92. doi: 10.1042/BST0331487.
- Pronk JC, van Kollenburg B, Scheper GC, van der Knaap MS. Vanishing white matter disease: a review with focus on its genetics. Ment Retard Dev Disabil Res Rev. 2006;12(2):123-8. doi: 10.1002/mrdd.20104.
- Scali O, Di Perri C, Federico A. The spectrum of mutations for the diagnosis of vanishing white matter disease. Neurol Sci. 2006 Sep;27(4):271-7. doi: 10.1007/s10072-006-0683-y.
- Scheper GC, Proud CG, van der Knaap MS. Defective translation initiation causes vanishing of cerebral white matter. Trends Mol Med. 2006 Apr;12(4):159-66. doi: 10.1016/j.molmed.2006.02.006. Epub 2006 Mar 20.
- van der Voorn JP, van Kollenburg B, Bertrand G, Van Haren K, Scheper GC, Powers JM, van der Knaap MS. The unfolded protein response in vanishing white matter disease. J Neuropathol Exp Neurol. 2005 Sep;64(9):770-5. doi: 10.1097/01.jnen.0000178446.41595.3a.
- van Kollenburg B, van Dijk J, Garbern J, Thomas AA, Scheper GC, Powers JM, van der Knaap MS. Glia-specific activation of all pathways of the unfolded protein response in vanishing white matter disease. J Neuropathol Exp Neurol. 2006 Jul;65(7):707-15. doi: 10.1097/01.jnen.0000228201.27539.50.
Partagez vos pensées ou expériences avec les autres dans notre communautés de patients.
Inscrivez-vous à la newsletter Patient
Votre dose hebdomadaire de conseils de santé clairs et fiables - rédigés pour vous aider à vous sentir informé, confiant et maître de la situation.
En vous abonnant, vous acceptez notre Politique de confidentialité. Vous pouvez vous désabonner à tout moment. Nous ne vendons jamais vos données.

